Practice
Featured experience
InSilico Medicine HK$2.62 billion IPO
We advised InSilico Medicine on its IPO and HKEX listing
Mastercard $1.8 billion acquisition of BVNK
We are advising Mastercard on the transaction
Sycamore Partners up to $23.7 billion acquisition of Walgreens Boots Alliance
We are advising Sycamore Partners on the transaction
Comcast spinoff of select cable television networks
We are advising Comcast on the transaction
Apria $141.7 million secondary offering
The shares are listed on the Nasdaq Global Select Market
First Advantage $345 million secondary offering
The shares are listed on the Nasdaq Global Select Market
Pacific Gas and Electric $1.75 billion first mortgage bonds offering
The investment-grade bonds are due 2022, 2023 and 2031
Revolution Medicines $250 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
SiTime $518 million follow-on offering
The shares are listed on the Nasdaq Global Market
Affimed $100 million at-the-market offering
The shares are listed on the Nasdaq Global Market
ANE HK$1.1 billion IPO
We advised ANE on its IPO and HKEX listing
Cryoport $403 million notes offering and concurrent $249 million stock offering
The company issued 0.75% convertible senior notes due 2026 and sold shares in a registered direct offering
Mountain & Co. I Acquisition $230 million IPO
We advised the SPAC on its IPO and Nasdaq listing
Square Mile Capital and Hackman Capital Partners acquire Kaufman Astoria Studios
We advised Square Mile Capital on the acquisition and the joint venture